# Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

> **NCT00301236** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 252 (—)

## Conditions studied

- ADHD, ADD

## Interventions

- **DRUG:** Dexmethylphenidate HCl extended-release capsules

## Key facts

- **NCT ID:** NCT00301236
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 252 (—)
- **Last updated:** 2007-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301236, "Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00301236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*